Aha life's essential 8
Aha life's essential 8 has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest paper, Apr 17, 2026: “Cardiovascular Health at Midlife and Alzheimer Disease Biomarkers”.
1 paper studies it2 findingsUpdated
See all 1 papers on aha life's essential 8
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“Compared to ideal LE8, intermediate (67.9% of participants) and poor (12.6%) LE8 was associated with lower Αβ42/40”
None of its findings points the other way.
- 1 lab in 1 country
- Funder: National Heart, Lung, and Blood Institute
- Humans1
What did studies of aha life's essential 8 find?
2Studies of aha life's essential 8 measured 2 outcomes: p-Tau217 and amyloid-beta 42/40 ratio.
p-Tau217
no changein humans1
1 study
p-Tau217
no changein humans1
Aha life's essential 8 was not clearly linked with p-Tau217 in humans.
Humansn = 1,406
Amyloid-beta 42/40 ratio
downin humans1
1 study
Amyloid-beta 42/40 ratio
downin humans1
Aha life's essential 8 is linked with lower amyloid-beta 42/40 ratio in humans (intermediate or poor vs ideal LE8) (adjusted mean difference: -2.37, 95% CI: -2.38 to -2.36 and -2.38, 95% CI: -2.40 to -2.36, respectively).
Humansintermediate or poor vs ideal LE8n = 1,406